How have BCDA and COCP total returns compared?

Over the past 10 years, BCDA delivered -46.74% and COCP delivered -39.76% annualized total return. Past performance doesn't predict future results.

BioCardia, Inc. (BCDA) vs Cocrystal Pharma, Inc. (COCP)

A side-by-side comparison of BioCardia, Inc. and Cocrystal Pharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BCDA

BioCardia, Inc.

$16M

$1.09HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

COCP

Cocrystal Pharma, Inc.

$15M

$1.11HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — BCDA vs COCP

growth of $100 · dividends reinvested · last 10y

BCDA -99.8% (-46.2%/yr)COCP -99.4% (-39.6%/yr)COCP compounded faster over this window

BCDA COCP

BCDA vs COCP: by the numbers

•BCDA is the larger company ($16M vs $15M market cap).
•Both run net losses; BCDA's is the smaller (0.00% vs -3011.52% net margin).

Metrics side by side

Valuation

Metric	BCDA	COCP
P/S ratio	N/A	46.38
P/B ratio	6.01	14.66

Profitability

Metric	BCDA	COCP
Gross margin	0.00%	0.00%
Operating margin	0.00%	0.00%
Net margin	0.00%	-3011.52%
ROE	-271.81%	-951.92%
ROIC	-273.70%	-497.29%

Growth (annualized)

Metric	BCDA	COCP
Revenue CAGR (5Y)	N/A	91.55%
Total return CAGR (5Y)	-61.39%	-37.50%

Frequently asked

How have BCDA and COCP total returns compared?: Over the past 10 years, BCDA delivered -46.74% and COCP delivered -39.76% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BCDA analysis Full COCP analysis Interactive comparison tool

Dig into the metrics

BioCardia ROE Cocrystal Pharma ROE BioCardia operating margin Cocrystal Pharma operating margin BioCardia revenue growth Cocrystal Pharma revenue growth BioCardia free cash flow Cocrystal Pharma free cash flow

BioCardia & Cocrystal Pharma appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.